They conducted an in vitro experiment on bladder cancer cell lines, demonstrating that BTZ-resistant cells had a low expression of HSPA1A which was associated with the revealed hypermethylation of the HSPA1A promoter. This evidence concerns the gene HSPA1A and urinary bladder carcinoma.